Connor, Clark & Lunn Investment Management (CC&L)’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-124,179
Closed -$361K 1257
2021
Q3
$361K Buy
124,179
+4,170
+3% +$12.1K ﹤0.01% 836
2021
Q2
$419K Buy
120,009
+72,138
+151% +$252K ﹤0.01% 818
2021
Q1
$164K Buy
+47,871
New +$164K ﹤0.01% 931